Could Naloxone Boost Survival in Cardiac Arrest Patients?
Surprisingly, naloxone was associated with improved clinical outcomes in both drug-related cardiac arrests and non-drug-related cardiac arrests.
Read MoreSurprisingly, naloxone was associated with improved clinical outcomes in both drug-related cardiac arrests and non-drug-related cardiac arrests.
Read MoreDesigns that prioritize comfort and accuracy are essential to ensuring patient compliance with wearable defibrillators during the critical post-discharge period.
Read MoreV-Wave’s Ventura Interatrial Shunt, designed for patients with heart failure and reduced ejection fraction, will join Johnson & Johnson MedTech’s portfolio under the new agreement.
Read MoreNew progress in wearable blood pressure monitoring is enabled by flexible electronics and machine learning.
Read MoreJob strain and effort-reward imbalance at work were associated with a greater chance of developing an abnormal heart rhythm condition, finds a new study.
Read More